ICYMI: Should the Specialty Drug Cost Debate Take a Breath? Data Proves Otherwise.

ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug Pricing Issue…? “…for anyone who thinks the players involved in this specialty drug pricing confrontation […]

Read more

ICYMI: Washington’s Role in High Drug Costs — Marketing Exclusivity and “Shadow Pricing”

ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision Drugs is Innovation, Not Cost “There are so many people now concerned about [high drug costs], and […]

Read more

ICYMI – Where’s Robert Stack When You Need Him?

ICYMI May 5, 2015  The New York Times: Runaway Drug Prices How companies set prices of specialty drugs for these and other complex diseases, like cancer and […]

Read more

ICYMI: High Drug Costs Impact Wall Street and Spark a New Initiative in the White House

April 28, 2015 Note: Distributing the New York Times article below is not an endorsement for President Obama’s proposed initiative.  New York Times: Obama Proposes That Medicare Be […]

Read more